A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
Network HIV Prevention Intervention for Drug Users
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The persistence of HIV and STD epidemics indicates that more effective, sustainable preventive interventions are needed, particularly for low-income, inner-city populations. This study will determine the effectiveness of a theoretically based peer outreach program in preventing HIV and STD transmission among adults in the Baltimore, Maryland area.
Participants will be randomly assigned to receive either a network-oriented peer program emphasizing one's social identity and the goals of protecting one's family and community or group cognitive behavioral therapy (CBT). The peer program will also train participants to provide HIV/STD education to their peers. Participants will be assessed at study entry and during several subsequent follow-up visits. At these study visits, participants will complete questionnaires about their sexual health knowledge and sexual behaviors. Participants and members of their peer network will have follow-up visits at Months 6, 12, and 18.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21231
- The Lighthouse
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria for CBT or Peer Intervention Participants:
- Female
- Age 18-55
- Did not inject drugs in the past 6 months
- Self-reported sex with at least 1 male partner in the past 6 months
Had at least 1 of the following sexual risk factors:
- More than 2 sex partners in the past 6 months
- STI diagnosis in the past 6 months
- Had a high risk sex partner in the past 90 days (i.e. a sex partner that injected drugs, smoked crack, was HIV+, or MSM)
Inclusion Criteria for Peer Network Participants:
- 18 years old or older
One of the following:
- Injected drugs
- Sex partner of index
- Social network member that the index felt comfortable talking to about HIV/STIs
Exclusion Criteria for All Participants:
- Currently enrolled in another HIV prevention intervention
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Intervention Condition: CHAT
Participants received the program over the course of five small group sessions and one individual session based on a harm reduction philosophy.
Participants were trained as Peer Mentors and were encouraged to talk to their family, friends, and sex partners about a range of sex risk reduction options.
|
The peer-oriented intervention program emphasized social identity and the goals of protecting family and community.
The peer program also trained participants to provide HIV/STD education to their peers.
|
|
Comparatore attivo: Comparison Condition: Standard of Care
The comparison condition consisted of one group session.
The session focused on HIV and STIs transmission and risk reduction information.
|
Group CBT will focus on teaching ways to modify thoughts and behaviors associated with risky sexual behaviors.
|
|
Nessun intervento: Network Participants
Index participants generated a list of network members during their baseline visits and were asked to recruit eligible network members into the study.
These network participants completed study interviews but did not participate in the intervention.
|
|
|
Nessun intervento: Non-randomized Baseline index participants
This arm includes those index participants that did not show up for randomization or did not recruit a network member were thus not eligible to be randomized into a study condition.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Sex Risk Behaviors: Number of Sex Partners (>=2 Sex Partners)
Lasso di tempo: 6 months
|
Number of participants that had 2 or more sex partners in the past 90 days.
|
6 months
|
|
Sex Risk Behaviors: Unprotected Sex With Non-main Partner (Past 90 Days)
Lasso di tempo: 12 months
|
12 months
|
|
|
Sex Risk Behaviors: Unprotected Anal Sex (Past 90 Days)
Lasso di tempo: 18 month
|
18 month
|
|
|
Sex Risk Behaviors: Unprotected Vaginal Sex (Past 90 Days)
Lasso di tempo: 18 months
|
18 months
|
|
|
Sex Risk Behaviors: Unprotected Sex With Main Partner (Past 90 Days)
Lasso di tempo: 18 months
|
18 months
|
|
|
Sex Risk Behaviors: Unprotected Sex With a Non-main Partner (Past 90 Days)
Lasso di tempo: 18 months
|
18 months
|
|
|
Sex Risk Behaviors: Any High Risk Sexual Behavior (Past 90 Days)
Lasso di tempo: 18 months
|
18 months
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
HIV Communication: Talk to Family About HIV or STIs (Past 6 Months)
Lasso di tempo: 6 months
|
6 months
|
|
HIV Communication: Talk to Family About HIV or STIs (Past 6 Months)
Lasso di tempo: 12 months
|
12 months
|
|
HIV Communication: Talk to Family About HIV or STIs (Past 6 Months)
Lasso di tempo: 18 months
|
18 months
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Carl A. Latkin, PhD, Johns Hopkins Bloomberg School of Public Health
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- R01MH066810 (Sovvenzione/contratto NIH degli Stati Uniti)
- DAHBR 9A-ASI
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .